1-9 of 9
viruses
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Virus-specific T cells for adenovirus infection after stem cell transplantation are highly effective and class II HLA restricted

Clinical Trials & Observations
Jeremy D. Rubinstein, Xiang Zhu, Thomas Leemhuis, Giang Pham, Lorraine Ray, Sana Emberesh, Sonata Jodele, Shawn Thomas, Jose A. Cancelas, Catherine M. Bollard, Patrick J. Hanley, Michael D. Keller, Olivia Grimley, Diana Clark, Teri Clark, Cecilia S. Lindestam Arlehamn, Alessandro Sette, Stella M. Davies, Adam S. Nelson, Michael S. Grimley, Carolyn Lutzko
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3309–3321.
https://doi.org/10.1182/bloodadvances.2021004456
Published: 2021
Includes: Supplemental data
Journal Articles

Platelets function as an acute viral reservoir during HIV-1 infection by harboring virus and T-cell complex formation

Sydney R. Simpson, Meera V. Singh, Stephen Dewhurst, Giovanni Schifitto, Sanjay B. Maggirwar
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4512–4521.
https://doi.org/10.1182/bloodadvances.2020002420
Published: 2020
Includes: Supplemental data
Journal Articles

Platelets mediate serological memory to neutralize viruses in vitro and in vivo

Waltraud C. Schrottmaier, Manuel Salzmann, Sigrun Badrnya, Marion Mussbacher, Julia B. Kral-Pointner, Susanne Morava, Anita Pirabe, Laura Brunnthaler, Koon C. Yaiw, Ulrike M. Heber, David Pereyra, Jan T. Andersen, Andreas Bergthaler, Cecilia Söderberg-Nauclér, Mikael C. I. Karlsson, Alice Assinger, Mattias N. E. Forsell
Journal: Blood Advances
Blood Adv (2020) 4 (16): 3971–3976.
https://doi.org/10.1182/bloodadvances.2020001786
Published: 2020
Includes: Supplemental data
Journal Articles

Complement inhibition does not impair the clinical antiviral capabilities of virus-specific T-cell therapy

Clinical Trials & Observations
Jeremy D. Rubinstein, Xiang Zhu, Carolyn Lutzko, Tom Leemhuis, Jose A. Cancelas, Sonata Jodele, Catherine M. Bollard, Patrick J. Hanley, Stella M. Davies, Michael S. Grimley, Adam S. Nelson
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3252–3257.
https://doi.org/10.1182/bloodadvances.2020002252
Published: 2020
Journal Articles

Influenza-induced thrombocytopenia is dependent on the subtype and sialoglycan receptor and increases with virus pathogenicity

A. J. Gerard Jansen, Thom Spaan, Hui Zhi Low, Daniele Di Iorio, Judith van den Brand, Malte Tieke, Arjan Barendrecht, Kerstin Rohn, Geert van Amerongen, Koert Stittelaar, Wolfgang Baumgärtner, Albert Osterhaus, Thijs Kuiken, Geert-Jan Boons, Jurriaan Huskens, Marianne Boes, Coen Maas, Erhard van der Vries
Journal: Blood Advances
Blood Adv (2020) 4 (13): 2967–2978.
https://doi.org/10.1182/bloodadvances.2020001640
Published: 2020
Journal Articles

Comprehensive metagenomic analysis of blastic plasmacytoid dendritic cell neoplasm

Jason Nomburg, Susan Bullman, Sun Sook Chung, Katsuhiro Togami, Mark A. Walker, Gabriel K. Griffin, Elizabeth A. Morgan, Nicole R. LeBoeuf, James A. DeCaprio, Matthew Meyerson, Andrew A. Lane
Journal: Blood Advances
Blood Adv (2020) 4 (6): 1006–1011.
https://doi.org/10.1182/bloodadvances.2019001260
Published: 2020
Includes: Supplemental data
Journal Articles

Abraham AA, John TD, Keller MD, et al. Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients. Blood Adv. 2019;3(14):2057-2068.

Journal: Blood Advances
Blood Adv (2019) 3 (16): 2453.
https://doi.org/10.1182/bloodadvances.2019000741
Published: 2019
Journal Articles

Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients

Clinical Trials & Observations
Allistair A. Abraham, Tami D. John, Michael D. Keller, C. Russell Y. Cruz, Baheyeldin Salem, Lauren Roesch, Hao Liu, Fahmida Hoq, Bambi J. Grilley, Adrian P. Gee, Hema Dave, David A. Jacobsohn, Robert A. Krance, Elizabeth. J. Shpall, Caridad A. Martinez, Patrick J. Hanley, Catherine M. Bollard
Journal: Blood Advances
Blood Adv (2019) 3 (14): 2057–2068.
https://doi.org/10.1182/bloodadvances.2019000201
Published: 2019
Includes: Supplemental data
Journal Articles

Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells

Clinical Trials & Observations
Barbara Withers, Emily Blyth, Leighton E. Clancy, Agnes Yong, Chris Fraser, Jane Burgess, Renee Simms, Rebecca Brown, David Kliman, Ming-Celine Dubosq, David Bishop, Gaurav Sutrave, Chun Kei Kris Ma, Peter J. Shaw, Kenneth P. Micklethwaite, David J. Gottlieb
Journal: Blood Advances
Blood Adv (2017) 1 (24): 2193–2205.
https://doi.org/10.1182/bloodadvances.2017010223
Published: 2017
Includes: Supplemental data